NCT00283959View on ClinicalTrials.gov

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 27, 2006

Primary Completion Date

May 8, 2008

Study Completion Date

May 8, 2008

Conditions
Fabry Disease
Interventions
DRUG

migalastat HCl

Trial Locations (2)

Unknown

Parkville

Porto Alegre

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY